Literature DB >> 27974250

The influence of genetic predisposition and autoimmune hepatitis inducing antigens in disease development.

Matthias Hardtke-Wolenski1, Janine Dywicki2, Katja Fischer2, Martin Hapke2, Maren Sievers2, Jerome Schlue3, Mark S Anderson4, Richard Taubert5, Fatih Noyan5, Michael P Manns2, Elmar Jaeckel5.   

Abstract

Autoimmune hepatitis (AIH) is defined as a chronic liver inflammation with loss of tolerance against hepatocytes. The etiology and pathophysiology of AIH are still poorly understood because reliable animal models are limited. Therefore, we recently introduced a model of experimental murine AIH by a self-limited adenoviral infection with the AIH type 2 antigen formiminotransferase cyclodeaminase (FTCD). We could demonstrate that break of humoral tolerance towards liver specific autoantigens like FTCD and cytochrome P450 2D6 (CYP2D6) is not dependent on the genetic background. However, the development of AIH in autoantibody positive animals is determined by genetic background genes. We could also show that the break of humoral tolerance is necessary but not sufficient for the development of AIH. In contrast the break of tolerance against the ubiquitously expressed nuclear antigens (ANAs) is strictly dependent on genetic predisposition. Priming with the UGA suppressor tRNA-associated protein (soluble liver antigen; SLA) is a strong inducer of ANA reactivity, but not sufficient to cause AIH development thereby questioning the importance of anti-SLA immune response as an important driver in AIH. Monogenetic mutations such as Aire-deficiency can cause AIH in otherwise genetically resistant strains.
CONCLUSION: The results have important implications for our understanding of the pathophysiology of AIH development and for the interpretation of humoral antibody responses in AIH.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Autoantibodies; Autoimmune hepatitis; Cytochrome P450 2D6; Experimental murine autoimmune hepatitis; Formiminotransferase cyclodeaminase; Genetic predisposition; Soluble liver antigen

Mesh:

Substances:

Year:  2016        PMID: 27974250     DOI: 10.1016/j.jaut.2016.12.001

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  10 in total

Review 1.  Myeloid Cells and Chronic Liver Disease: a Comprehensive Review.

Authors:  Min Lian; Carlo Selmi; M Eric Gershwin; Xiong Ma
Journal:  Clin Rev Allergy Immunol       Date:  2018-04       Impact factor: 8.667

Review 2.  Autoimmunity in 2017.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2018-12       Impact factor: 8.667

Review 3.  Mouse Models of Liver Parenchyma Injuries and Regeneration.

Authors:  Yuan Du; Wencheng Zhang; Hua Qiu; Canjun Xiao; Jun Shi; Lola M Reid; Zhiying He
Journal:  Front Cell Dev Biol       Date:  2022-05-05

Review 4.  Autoantibodies in Autoimmune Hepatitis: Can Epitopes Tell Us about the Etiology of the Disease?

Authors:  Urs Christen; Edith Hintermann
Journal:  Front Immunol       Date:  2018-02-16       Impact factor: 7.561

5.  The JAK inhibitor tofacitinib ameliorates immune‑mediated liver injury in mice.

Authors:  Han Wang; Xinxia Feng; Ping Han; Yu Lei; Yujia Xia; Dean Tian; Wei Yan
Journal:  Mol Med Rep       Date:  2019-10-16       Impact factor: 2.952

6.  Splenectomy Prior to Experimental Induction of Autoimmune Hepatitis Promotes More Severe Hepatic Inflammation, Production of IL-17 and Apoptosis.

Authors:  Laura Elisa Buitrago-Molina; Janine Dywicki; Fatih Noyan; Martin Trippler; Julia Pietrek; Jerome Schlue; Michael P Manns; Heiner Wedemeyer; Elmar Jaeckel; Matthias Hardtke-Wolenski
Journal:  Biomedicines       Date:  2021-01-09

7.  Toward solving the etiological mystery of primary biliary cholangitis.

Authors:  Atsushi Tanakaa; Patrick Sc Leung; Howard A Young; M Eric Gershwin
Journal:  Hepatol Commun       Date:  2017-05-18

8.  Therapeutic and immunological interventions in primary biliary cholangitis: from mouse models to humans.

Authors:  Atsushi Tanaka; Patrick S C Leung; Howard A Young; M Eric Gershwin
Journal:  Arch Med Sci       Date:  2017-10-24       Impact factor: 3.318

9.  Plasma proteomic analysis of autoimmune hepatitis in an improved AIH mouse model.

Authors:  Han Wang; Wei Yan; Zuohua Feng; Yuan Gao; Liu Zhang; Xinxia Feng; Dean Tian
Journal:  J Transl Med       Date:  2020-01-06       Impact factor: 5.531

Review 10.  Regulatory T Cells in Autoimmune Hepatitis: Unveiling Their Roles in Mouse Models and Patients.

Authors:  Han Wang; Xinxia Feng; Wei Yan; Dean Tian
Journal:  Front Immunol       Date:  2020-10-07       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.